Clinical Trials Browser

Recurrence × dacomitinib × Thoracic × Clear all

NCT04768491 2021-02-24

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

Carcinoma, Non-Small-Cell Lung, Recurrence